Literature DB >> 1791081

Calculated empiric antimicrobial therapy for mixed surgical infections.

D H Wittmann1, J M Bergstein, C Frantzides.   

Abstract

In acute life-threatening surgical infections requiring immediate institution of antimicrobial therapy before bacteriological results are available, antibiotic treatment must be empiric. For best efficacy a more sophisticated form of empiric therapy is offered, termed calculated antibiotic therapy (CAT). Calculated antibiotic therapy requires consideration of a) typical bacterial spectrum; b) bacterial pathogenicity and synergism; c) antibacterial concentrations at the site of infection; d) toxicity and adverse effects; e) interaction with immune response; and f) results of properly conducted trials. Intraabdominal infections are used as an example here to assess the efficacy of clinically used cephalosporins and penicillins for determination of calculated antibiotic therapy. CAT identifies Escherichia coli and Bacteroides fragilis as the most important pathogens for intraabdominal infections and determines the most effective antibiotics at the tissue breakpoint, which is defined as the minimal concentration maintained for more than 90% of the dosage interval period at the infected tissues. At the tissue breakpoint calculated antibiotic therapy identifies cefotaxime-generation cephalosporins to be fully (100%) active against the most important aerobic pathogen E. coli and metronidazole as fully active against the important obligate anaerobe B. fragilis. Calculated antibiotic therapy becomes relatively important, since impeccably controlled clinical therapeutic trials as a foundation for therapy are rarely published.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1791081     DOI: 10.1007/bf01715776

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  12 in total

1.  The bacteriology of intra-abdominal infections.

Authors:  B Lorber; R M Swenson
Journal:  Surg Clin North Am       Date:  1975-12       Impact factor: 2.741

2.  [Wound healing disorders and septic surgery. 1. Wound healing disorders].

Authors:  H Dittrich
Journal:  Chirurg       Date:  1971-07       Impact factor: 0.955

3.  Potentiation of phagocytosis of pathogenic bacteria by exposure to low concentrations of antibiotics.

Authors:  C G Gemmell
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

4.  Perspectives in surgical infections.

Authors:  W A Altemeier
Journal:  Surg Clin North Am       Date:  1980-02       Impact factor: 2.741

5.  Classics in infectious diseases: on the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae by Alexander Fleming, Reprinted from the British Journal of Experimental Pathology 10:226-236, 1929.

Authors:  A Fleming
Journal:  Rev Infect Dis       Date:  1980 Jan-Feb

6.  Management of anaerobic infections.

Authors:  S M Finegold; J G Bartlett; A W Chow; D J Flora; S L Gorbach; E J Harder; F P Tally
Journal:  Ann Intern Med       Date:  1975-09       Impact factor: 25.391

Review 7.  Antibiotic trials in intra-abdominal infections. A critical evaluation of study design and outcome reporting.

Authors:  J S Solomkin; J L Meakins; M D Allo; E P Dellinger; R L Simmons
Journal:  Ann Surg       Date:  1984-07       Impact factor: 12.969

Review 8.  A review. Lessons from an animal model of intra-abdominal sepsis.

Authors:  J G Bartlett; A B Onderdonk; T Louie; D L Kasper; S L Gorbach
Journal:  Arch Surg       Date:  1978-07

9.  Third-generation cephalosporins for polymicrobial surgical sepsis.

Authors:  H H Stone; P R Strom; T C Fabian; W E Dunlop
Journal:  Arch Surg       Date:  1983-02

10.  [Moxalactam - a beta-lactam antibiotic in the monotherapy of severe infections in surgery. Clinico-bacteriological study of 35 patients].

Authors:  H R Gonzenbach; W Sonnabend
Journal:  Schweiz Med Wochenschr       Date:  1981-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.